What You Need to Know About Orthofix International NV's Foreign Corruption Woes

Orthofix International in January entered into its second Foreign Corrupt Practices Act (FCPA) settlement in less than 5 years: a $6.1 million disposition with the Securities and Exchange Commission to resolve allegations that the company’s Brazilian subsidiary made improper payments to doctors at government-owned hospitals in Brazil to increase sales.

The FCPA prohibits corruptly providing anything of value to a “foreign official,” including doctors at state-owned hospitals, for the purpose of obtaining or retaining business. It also requires U.S. securities issuers to maintain accurate books and records and implement sufficient internal accounting controls.

Back to news